Charles Schwab’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-711,005
| Closed | -$30M | – | 3668 |
|
|
2023
Q2 | $30M | Sell |
711,005
-24,153
| -3% | -$977K | 0.01% | 1215 |
|
|
2023
Q1 | $26.2M | Sell |
735,158
-246,607
| -25% | -$8.95M | 0.01% | 1268 |
|
|
2022
Q4 | $36M | Buy |
981,765
+125,378
| +15% | +$4.96M | 0.01% | 1025 |
|
|
2022
Q3 | $40.4M | Buy |
856,387
+48,851
| +6% | +$3.16M | 0.01% | 893 |
|
|
2022
Q2 | $57.9M | Buy |
807,536
+79,736
| +11% | +$5.83M | 0.02% | 670 |
|
|
2022
Q1 | $58.9M | Buy |
727,800
+36,278
| +5% | +$3.07M | 0.02% | 764 |
|
|
2021
Q4 | $71M | Buy |
691,522
+23,217
| +3% | +$2.23M | 0.02% | 695 |
|
|
2021
Q3 | $58.5M | Buy |
668,305
+23,117
| +4% | +$2.09M | 0.02% | 767 |
|
|
2021
Q2 | $57.7M | Buy |
645,188
+109,998
| +21% | +$9.29M | 0.02% | 771 |
|
|
2021
Q1 | $40.6M | Buy |
535,190
+50,108
| +10% | +$3.78M | 0.01% | 971 |
|
|
2020
Q4 | $33M | Buy |
485,082
+75,226
| +18% | +$4.69M | 0.01% | 1035 |
|
|
2020
Q3 | $21.8M | Buy |
409,856
+35,570
| +10% | +$2.12M | 0.01% | 1144 |
|
|
2020
Q2 | $21.8M | Sell |
374,286
-212,567
| -36% | -$11.4M | 0.01% | 1105 |
|
|
2020
Q1 | $23.1M | Buy |
586,853
+15,165
| +3% | +$887K | 0.01% | 919 |
|
|
2019
Q4 | $34M | Buy |
571,688
+25,426
| +5% | +$1.37M | 0.02% | 863 |
|
|
2019
Q3 | $29.1M | Buy |
546,262
+38,227
| +8% | +$1.96M | 0.02% | 913 |
|
|
2019
Q2 | $26M | Buy |
508,035
+113,923
| +29% | +$5.3M | 0.02% | 962 |
|
|
2019
Q1 | $20.4M | Buy |
394,112
+36,306
| +10% | +$1.76M | 0.01% | 1091 |
|
|
2018
Q4 | $14.1M | Buy |
357,806
+9,480
| +3% | +$440K | 0.01% | 1213 |
|
|
2018
Q3 | $18M | Buy |
348,326
+46,185
| +15% | +$2.26M | 0.01% | 1212 |
|
|
2018
Q2 | $14.2M | Sell |
302,141
-24,064
| -7% | -$996K | 0.01% | 1344 |
|
|
2018
Q1 | $11.6M | Buy |
326,205
+32,726
| +11% | +$1.28M | 0.01% | 1392 |
|
|
2017
Q4 | $12.8M | Buy |
293,479
+27,328
| +10% | +$1.28M | 0.01% | 1313 |
|
|
2017
Q3 | $13.9M | Sell |
266,151
-38,901
| -13% | -$2.17M | 0.01% | 1178 |
|
|
2017
Q2 | $17.8M | Sell |
305,052
-17,789
| -6% | -$924K | 0.02% | 948 |
|
|
2017
Q1 | $14.8M | Sell |
322,841
-3,574
| -1% | -$178K | 0.01% | 1033 |
|
|
2016
Q4 | $17.2M | Sell |
326,415
-40,907
| -11% | -$1.98M | 0.02% | 852 |
|
|
2016
Q3 | $16.4M | Sell |
367,322
-16,988
| -4% | -$737K | 0.02% | 817 |
|
|
2016
Q2 | $14.7M | Buy |
384,310
+185,897
| +94% | +$8.17M | 0.02% | 824 |
|
|
2016
Q1 | $8.18M | Buy |
198,413
+94,670
| +91% | +$3.9M | 0.01% | 1178 |
|
|
2015
Q4 | $5.03M | Buy |
103,743
+18,520
| +22% | +$824K | 0.01% | 1514 |
|
|
2015
Q3 | $3.41M | Buy |
85,223
+52,816
| +163% | +$2.31M | 0.01% | 1730 |
|
|
2015
Q2 | $1.3M | Buy |
32,407
+8,968
| +38% | +$309K | ﹤0.01% | 2298 |
|
|
2015
Q1 | $768K | Buy |
23,439
+5,328
| +29% | +$147K | ﹤0.01% | 2471 |
|
|
2014
Q4 | $466K | Buy |
+18,111
| New | +$431K | ﹤0.01% | 2646 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
Charles Schwab's SYNH Position: Q3 2023 in Review
Charles Schwab sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 711,005 shares — an estimated $30M sold.
Charles Schwab first reported a position in SYNH in Q4 2014 and held it in 35 quarters. The position peaked at $71M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- Charles Schwab reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Charles Schwab sold 711,005 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $30M.
- Charles Schwab first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 35 quarters.
- Charles Schwab's Syneos Health, Inc. Class A Common Stock position peaked at $71M in Q4 2021.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.